Cardiovascular disease is the leading cause of mortality in U.S. Hispanics. The prevalence of risk factors for cardiovascular disease is higher for Hispanics than for non-Hispanic whites and is increasing. Hispanics face unique social, cultural, and language barriers gaining access to care. These barriers are a major reason that Hispanics are less likely to receive treatment for cardiovascular disease risk factors. For these reasons, improving the primary prevention of cardiovascular disease in Hispanics is the broad, long-term objective of the proposed research. In response to NHLBI RFA HL-04-002, this project will develop a partnership between Denver Health (DH), a minority-serving healthcare system, and the University of Colorado Health Sciences Center (UCHSC), a research-intensive medical center. The first Specific Aim of the project is to develop and evaluate an interactive computer-based tool to improve community-based recognition of cardiovascular risk factors and to improve self-management skills, including adherence with clinic visits. The tool will be culturally-sensitive and bilingual. The second Specific Aim is to test the ability of a nurse-based disease management program to improve control of risk factors. Under this aim, DH's unique computerized information system will be used to develop a registry of patients with hypertension, and to characterize patients' overall risk for cardiovascular disease and their risk for non-adherent behavior. A randomized clinical trial will be used to assess the impact of a nurse-based disease management intervention in those at highest risk and with a history of non-adherence. The intervention will be based on programs already in place at DH but will be modified in response to input from community-based focus groups.
Specific Aims 3 and 4 will seek to refine current cardiovascular risk profiling in ways specific to Hispanics.
Specific Aim 3 will assess ethnic differences in the relationship between traditional risk factors (diabetes, hypertension, smoking, hyperlipidemia) and pre-clinical markers of cardiovascular disease (left ventricular mass, carotid intima media thickness, and brachial artery reactivity) over time.
Specific Aim 4 will assess the relationship among the traditional risk factors, pre-clinical markers, and a panel of circulating inflammatory markers. Also under Specific Aim 4, a randomized, placebo controlled trial will assess the efficacy of """"""""statin"""""""" medications to reduce circulating levels of these inflammatory markers.
Specific Aims 5 and 6 will develop educational programs to increase the cultural proficiency of clinical researchers, increase minority researcher participation in cardiovascular prevention research, and assist junior DH physicians in developing research careers in cardiovascular prevention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL079160-05
Application #
7496019
Study Section
Special Emphasis Panel (ZHL1-CSR-R (S2))
Program Officer
Desvigne-Nickens, Patrice
Project Start
2004-09-30
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2010-08-31
Support Year
5
Fiscal Year
2008
Total Cost
$548,686
Indirect Cost
Name
Denver Health and Hospital Authority
Department
Type
DUNS #
093564180
City
Denver
State
CO
Country
United States
Zip Code
80204
Pflederer, Matthew C; Long, Carlin S; Beaty, Brenda et al. (2016) Longitudinal Changes in Vascular Risk Markers and Mortality Rates among a Latino Population with Hypertension. Tex Heart Inst J 43:131-6
Krantz, Mori J; Havranek, Edward P; Pereira, Rocio I et al. (2015) Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: a randomized pilot study. J Negat Results Biomed 14:21
Krantz, Mori J; Sabel, Allison L; Sagar, Utpal et al. (2012) Factors influencing QT prolongation in patients hospitalized with severe anorexia nervosa. Gen Hosp Psychiatry 34:173-7
Padilla, Ricardo; Steiner, John F; Havranek, Edward P et al. (2011) A comparison of different measures of acculturation with cardiovascular risk factors in Latinos with hypertension. J Immigr Minor Health 13:284-92
Krantz, Mori J; Long, Carlin S; Hosokawa, Patrick et al. (2011) Pulse wave velocity and carotid atherosclerosis in white and Latino patients with hypertension. BMC Cardiovasc Disord 11:15
Berger, Jeffrey S; Lala, Anuradha; Krantz, Mori J et al. (2011) Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. Am Heart J 162:115-24.e2
Sheridan, Stacey L; Viera, Anthony J; Krantz, Mori J et al. (2010) The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med 170:230-9
Hanratty, Rebecca; Chonchol, Michel; Miriam Dickinson, L et al. (2010) Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant 25:801-7
Hurley, Laura P; Dickinson, L Miriam; Estacio, Raymond O et al. (2010) Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes 3:181-7
DeBiasi, Roberta L; Robinson, Bridget A; Leser, J Smith et al. (2010) Critical role for death-receptor mediated apoptotic signaling in viral myocarditis. J Card Fail 16:901-10

Showing the most recent 10 out of 22 publications